Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with
Omer Faruk Yolcu1, Seyfettin Köklü, Osman Yüksel
1Department of Gastroenterology, Türkiye Yülksek Ihtisas Hospital, Ankara.
Background/Aims:
To determine the serum vascular endothelial growth factor receptor-1 (VEGFR-1) levels in hepatocellular carcinoma patients and its correlations with the clinical and laboratory parameters.
Methodology:
Serum VEGFR-1 levels were measured in 18 biopsy-proven treatment-naive hepatocellular carcinoma patients (female/male: 5/13; mean age: 59.22 +/- 13.15 years) and in age- and sex-matched healthy controls. Possible associations were also evaluated between serum VEGFR-1 levels and etiology and severity of chronic liver disease, serum alpha-fetoprotein levels, presence of ascites and portal vein thrombosis, and tumor number, size and stage.
Results:
Serum VEGFR-1 levels were undetectable in all healthy subjects, while all of the patients with hepatocellular carcinoma had increased VEGFR-1 (p < 0.001). Serum VEGFR-1 levels did not correlate with the clinical and laboratory parameters and tumor characteristics in hepatocellular carcinoma.
Conclusions:
VEGFR-1 is involved in the regulation of carcinogenesis in hepatocellular carcinoma.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
02:38Mitogens and the Cell Cycle
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...